Author: WalshBScH Kate
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.29, Iss.3, 2012-03, pp. : 249-250
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
-Amyloid in Alzheimer's disease: friend or foe?
Inpharma, Vol. 1, Iss. 1378, 2003-01 ,pp. :
By Nunney Jacky Raynor David K. Knapp Peter Closs S. Jose
Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. :
Cost effectiveness of risperidone: is compliance the key?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 614, 2010-01 ,pp. :
Concordance: is it just another version of compliance?
Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. :